Skip to content
14 November · 06:30 UTCFollow AstraZeneca by emailFollow

AZN · story · 14 November

AstraZeneca reduces its US sales workforce by 600 positions

AstraZeneca · 14 headlines from 13 outlets, on 14 November 2026.

The story

−2.6slightly negative
Headlines14
Outlets13
Days114 November

Bloomberg reported AstraZeneca is cutting about 600 US sales roles under a $1.5bn savings plan.

The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

How each outlet covered it · 13 outlets

The 10 outlets with the most impact on the tone

Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.

Source: MarketFrame news analysis

The 10 outlets with the most impact on the tone. Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone. Source: MarketFrame news analysis
outletAverage tone
Investing.com−2.5
FirstWord Pharma−3.3
Briefs Finance−3.3
tokenpost.com−3.3
Fierce Pharma−2.5
Reuters−2.5
Bloomberg−2.5
Euronext Markets: Real-time Stock Market Data | live−2.5
MarketScreener−2.5
TradingView−2.5
OutletHeadlinesAverage tone
Investing.com2−2.5
FirstWord Pharma1−3.3
Briefs Finance1−3.3
tokenpost.com1−3.3
Fierce Pharma1−2.5
Reuters1−2.5
Bloomberg1−2.5
Euronext Markets: Real-time Stock Market Data | live1−2.5
MarketScreener1−2.5
TradingView1−2.5
All 13 outlets
OutletHeadlinesAverage tone
Demócrata1−2.5
Yahoo Finance1−2.5
Asianet Newsable1−1.7

One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.

Day by day · 1 day, strongest headlines first

Saturday 14 November 202614 headlines · Bloomberg reported AstraZeneca is cutting about 600 US sales roles under a $1.5bn savings plan.−2.6
ToneWhat the article reported, and why it scored that waySource
−3.3Commercial role reductions reported in US.FirstWord Pharma (opens the article) ↗
−3.3Staff reductions in respiratory sales, though tied to savings drive.}Briefs Finance (opens the article) ↗
−3.3Marketing roles cut across two drug businesses.tokenpost.com (opens the article) ↗
−2.5Sales job cuts as part of cost savings plan.Fierce Pharma (opens the article) ↗
−2.5Report of US sales job cuts.Reuters (opens the article) ↗
−2.5Sales staff reduced as savings programme proceeds.Bloomberg (opens the article) ↗
−2.5Report of US sales job cuts.Euronext Markets: Real-time Stock Market Data | live (opens the article) ↗
−2.5Staff trimmed under cost-cutting programme.MarketScreener (opens the article) ↗
6 more headlines that day
ToneWhat the article reported, and why it scored that waySource
−2.5Sales staff reduced as savings programme proceeds.TradingView (opens the article) ↗
−2.5US jobs cut within large cost-saving overhaul.Investing.com (opens the article) ↗
−2.5Report of US sales job cuts.Investing.com (opens the article) ↗
−2.5Sales network reduced as part of savings plan.Demócrata (opens the article) ↗
−2.5US jobs cut within large cost-saving overhaul.Yahoo Finance (opens the article) ↗
−1.7Sales positions removed to finance pipeline investment.Asianet Newsable (opens the article) ↗

Follow by email

A short, free morning email on how the news treated AstraZeneca: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

How it works. Every morning an AI model reads the UK business news about each FTSE 100 company and scores how good or bad it is for the company, from −10 to +10. Pages update by about 07:45 UK time.

Not investment advice. MarketFrame rates the tone of news coverage. It is general information, not a recommendation to buy or sell anything. The scores are not share-price data or forecasts: a good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.

Data to 06:30 UTC, 14 November · 712 headlines · 86 companiesMade by Adapt Progress Evolve Limited, a UK company · Privacy · Terms · RSS · API · llms.txt